Introduction: Among patients with psoriasis (PsO), switching therapies is common due to poor treatment outcomes, including lack of efficacy or safety/tolerability issues. This study compared real-world switch rates among patients with PsO treated with biologics over a 36-month period.
No takes yet. Share an insight, caveat, or question.
Armstrong et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: